These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 6986664
1. Sulphinpyrazone in the prevention of cardiac death after myocardial infarction. S Afr Med J; 1980 Mar 01; 57(9):301-2. PubMed ID: 6986664 [No Abstract] [Full Text] [Related]
5. Sulfinpyrazone in the prevention of sudden death after myocardial infarction. Anturane Reinfarction Trial Research Group. N Engl J Med; 1980 Jan 31; 302(5):250-6. PubMed ID: 6985706 [Abstract] [Full Text] [Related]
6. Sulphinpyrazone in acute myocardial infarction: studies on cardiac rhythm and renal function. Wilcox RG, Richardson D, Hampton JR, Mitchell JR, Banks DC. Br Med J; 1980 Aug 23; 281(6239):531-4. PubMed ID: 7000264 [Abstract] [Full Text] [Related]
8. Myocardial re-infarction and sulphinpyrazone. N Z Med J; 1978 Aug 09; 88(617):106. PubMed ID: 362256 [No Abstract] [Full Text] [Related]
9. Sulphinpyrazone. Hopkins S. Nurs Mirror; 1980 Aug 28; 151(9):36. PubMed ID: 6995949 [No Abstract] [Full Text] [Related]
10. A serial study of platelet reactivity throughout the first six months after myocardial infarction: its modification by sulphinpyrazone. Kubik MM, Richardson SG. Postgrad Med J; 1987 May 28; 63(739):351-6. PubMed ID: 3118351 [Abstract] [Full Text] [Related]
11. Does sulphinpyrazone prevent recurrence of myocardial infarction? Lancet; 1982 Mar 27; 1(8274):735-6. PubMed ID: 6122022 [No Abstract] [Full Text] [Related]
12. The FDA's critique of the anturane reinfarction trial. Temple R, Pledger GW. N Engl J Med; 1980 Dec 18; 303(25):1488-92. PubMed ID: 7432418 [No Abstract] [Full Text] [Related]
13. Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial. Anturane Reinfarction Trial Research Group. N Engl J Med; 1978 Feb 09; 298(6):289-95. PubMed ID: 340942 [Abstract] [Full Text] [Related]